Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00737490 · ClinicalTrials.gov registry record · NA
Does Echocardiographically Guided Ventriculo-Ventricular Optimization Yield a Sustained Improvement in Echocardiographic Parameters in Cardiac Resynchronization Therapy Patients? (DEVISE CRT)
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00737490 is a NA study that has completed, run by Duke University. The registered enrollment target is 40 participants.
The verdict
NCT00737490, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether using an echocardiogram (a painless test where ultrasound is used to see your heart) while using mild electrical stimulation from your own CRT-D device to stimulate the ventricles (the lower chambers of the heart) to squeeze one slightly earlier than the other will show a sustained increase your heart's productivity (Cardiac Output (CO)), following implantation of a Cardiac Resynchronization Device (CRT-D). We believe that squeezing some parts of the heart earlier than others may make the heart a stronger pump.
Interventions
- OTHER "Sequential Arm" (Promote , model # 2207-36 or Atlas HF , model # V-343)
- OTHER "Simultaneous Arm" (Promote , model # 2207-36 or Atlas HF , model # V-343)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2005-06 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00737490
The ClinicalTrials.gov registry entry for NCT00737490 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which "Sequential Arm" (Promote , model # 2207-36 or Atlas HF , model # V-343) is the first listed.
NCT00737490 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00737490 about?
NCT00737490 is a clinical study titled "Does Echocardiographically Guided Ventriculo-Ventricular Optimization Yield a Sustained Improvement in Echocardiographic Parameters in Cardiac Resynchronization Therapy Patients? (DEVISE CRT)". The purpose of this study is to determine whether using an echocardiogram (a painless test where ultrasound is used to see your heart) while using mild electrical stimulation from your own CRT-D device to stimulate the ventricles (the lower chambers of the heart) to squeeze one slightly earlier than...
What is the current status of trial NCT00737490?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2005-06. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00737490?
The interventions under investigation include: "Sequential Arm" (Promote , model # 2207-36 or Atlas HF , model # V-343) (OTHER), "Simultaneous Arm" (Promote , model # 2207-36 or Atlas HF , model # V-343) (OTHER).
Who is sponsoring clinical trial NCT00737490?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.